New Zealand vs Norway: Proportion of isolates with decreased susceptibility or resistance
New Zealand
0.4386
in 2017
Norway
0
in 2018
New Zealand rank
22nd
Norway rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- New Zealand
- Norway
How they compare
New Zealand currently reports 0.4386 against 0 in Norway, a difference of 0.4386.
Across all 9 years both countries report, Norway has been ahead every year.
New Zealand ranks 22nd and Norway ranks 25th of 51 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.9091 | 0.9091 | Norway |
| 2010s | 0.3595 | 3.35 | 2.99 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, New Zealand or Norway?
- New Zealand, at 0.4386 against 0 in Norway as of 2017.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between New Zealand and Norway?
- 0.4386, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Norway?
- 9 years are reported by both, from 2009 to 2017.
- How do New Zealand and Norway rank globally for proportion of isolates with decreased susceptibility or resistance?
- New Zealand ranks 22nd and Norway ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.